A study published in PLOS ONE last week attempted to characterise the reasons why trials (listed on www.clinicaltrials.gov) were terminated, and also examined the availability of results from these trials. … Continue Reading Terminated trials in the ClinicalTrials.gov results database: reasons for termination and availability of results
This year marks the 10th anniversary of the formation of the International Society for Medical Publication Professionals (ISMPP). To mark this occasion, ISMPP have developed a presentation that provides an … Continue Reading The International Society for Medical Publication Professionals (ISMPP): a decade of achievements
Following a recent series of articles and an accompanying editorial in the NEJM on conflict of interest, the journal is now running a reader poll on this issue. The poll … Continue Reading Poll from the New England Journal of Medicine on conflicts of interest
A blog by Altmetric published yesterday, attempts to answer questions from researchers about Altmetrics, why the scores are useful, how the score is calculated and weighted, and also what is … Continue Reading Numbers behind numbers: The Altmetric Score and sources explained
A blog by Elsevier published in the past week authored by Dr. Filipe Branco dos Santos, Assistant Professor of Biological Sciences at the University of Amsterdam, argues that we could … Continue Reading It’s time for academic writing to evolve – “Science is exciting, so why do we write about it in such a dull way?”
An article in PeerJ this week provides an overview and analysis of the currently available Mega Journals – including PLOS ONE, BMJ Open, PeerJ and others. The article summarises the … Continue Reading Overview of currently available mega-journals: have they reached their limits to growth?
A blog in MedPage Today this week, F. Perry Wilson (an assistant professor of medicine at the Yale School of Medicine) provides a very interesting overview of how statistics can … Continue Reading Lies, damned lies and statistics (relating to medical publications)
There are obvious benefits associated with open data policies for the scientific community. As a consequence, research organisations are increasingly adopting open data policies as a requisite for publication. However, … Continue Reading What is the impact of open data policies on participation in clinical trials?
GSK’s road to increasing clinical trial transparency is laid out in a document released by EFPIA today. This “road map” can be found here. Researchers can submit proposals and request … Continue Reading GSK’s road to clinical trial transparency
The videos are now available on YouTube from the recent Evidence Live 2015 meeting in Oxford. Presentations available include: Iona Heath – Eminence or evidence-based medicine: why this question is … Continue Reading Videos now available from Evidence Live 2015
The Journal of Microbiology and Biology Education (JMBE) have released a video in the past week relating to publication ethics. The video (see below) discusses the importance of scientific ethics … Continue Reading Ethics in science: trends in research misconduct on the rise (video)
The UK Health Research Authority is facing a legal review over its work to advance clinical trial transparency, the Guardian reported this week. The legal review was launched by Richmond … Continue Reading Contract research organisation using court action to challenge data transparency
Within the last week, the BMJ has published an official extension of the CONSORT 2010 Statement for reporting N-of-1 trials. This guidance from the EQUATOR Network (www.equator-network.org) provides a set … Continue Reading CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement
An Editorial in this week’s New England Journal of Medicine provides a thoughtful overview of the relationship between physicians and industry, and warns of the dangers of bias against industry-sponsored … Continue Reading Understanding industry bias and potential conflicts of interest